Related Experiment Videos
Is noninvasive risk stratification sufficient, or should all patients undergo cardiac catheterization and angiography
Insights
Early cardiac catheterization after myocardial infarction is practical for most patients, offering key prognostic data and guiding long-term management. This invasive approach may be more efficient than noninvasive risk stratification alone.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Noninvasive risk stratification is a common approach for patients post-myocardial infarction.
- However, limitations exist in the accuracy and completeness of noninvasive assessments.
Purpose of the Study:
- To evaluate the practicality and benefits of early cardiac catheterization and angiography in patients following an uncomplicated myocardial infarction.
- To compare the efficacy of early invasive assessment versus noninvasive risk stratification.
Main Methods:
- Review of existing data and clinical rationales for early cardiac catheterization.
- Analysis of prognostic variables provided by cardiac catheterization and angiography.
- Consideration of limitations in noninvasive testing strategies.
Main Results:
- Early cardiac catheterization is often necessary for specific subgroups, including those with complications, on thrombolytic therapy, or with inconclusive noninvasive tests.
- Cardiac catheterization provides crucial prognostic information on coronary artery disease extent and left ventricular function.
- Noninvasive strategies have limitations, and approximately 70% of patients may have abnormal or inconclusive results.
Conclusions:
- Early cardiac catheterization and angiography represent a practical and potentially superior approach for risk stratification in most patients after myocardial infarction.
- This invasive strategy aids in planning optimal long-term management and identifying candidates for revascularization.
- Careful clinical judgment is essential to avoid unnecessary procedures and ensure comprehensive patient care, including risk factor modification.
Abstract:
From the foregoing discussion, it becomes apparent that although noninvasive risk stratification is a reasonable approach to assessment of patients following an uncomplicated myocardial infarction, the performance of early cardiac catheterization and angiography on nearly all such patients is not unreasonable and may in fact be the most practical approach. The basis for this rationalization may be summarized as follows: 1. Many subgroups will need early catheterization anyway a. Myocardial infarction complicated by recurrent ischemia, heart failure, or complex ventricular arrhythmias b. Patients receiving thrombolytic treatment c. "Young" patients (less than 50 years old?) d. "Older" patients (over ages 65 to 70?) in otherwise good medical condition e. Patients unable to exercise f. Patients with abnormal or inconclusive noninvasive test results (approximately 70 percent of patients) 2. Cardiac catheterization and angiography as a single test provides the two most powerful prognostic variables following myocardial infarction, namely, the extent of coronary artery disease and residual left ventricular function. This knowledge is reassuring to both physician and patient and allows for planning of optimal long-term management. 3. Certain limitations exist in noninvasive risk assessment strategies. 4. This approach need not be significantly more costly, if all tests are used wisely. The major risk inherent in the definition of the extent of coronary artery disease in all survivors of acute myocardial infarction might be the performance of unnecessary revascularization procedures (percutaneous transluminal coronary angioplasty or coronary bypass surgery). The burden rests with the individual clinician to (1) collect all useful and necessary data; (2) assess reliability and accuracy of various tests available at one's own institution; (3) avoid performing unnecessary and repetitive tests; (4) interpret the data in the proper context; and (5) counsel patients appropriately, correctly, and judiciously about their prognosis and therapeutic options. In this manner, all patients who might benefit appropriately from revascularization can be discovered early and offered this therapeutic option. Other patients can also be managed more appropriately; for example, those who are truly at very low risk (normal left ventricular function and either normal coronary arteries or "mild" coronary artery disease). However, it is most important to avoid unnecessary revascularization procedures. Although this discussion has focused on noninvasive and invasive testing following myocardial infarction, it is necessary to emphasize that comprehensive management of coronary artery disease and its complications should not be neglected in these patients; for example, control or amelioration of risk factors for coronary artery disease is mandatory in all these patients, and in their families as well.